Blockage of tumor necrosis factor prevents intestinal mucosal inflammation through down-regulation of interleukin-23 secretion
- 30 November 2007
- journal article
- Published by Elsevier in Journal of Autoimmunity
- Vol. 29 (2-3) , 187-194
- https://doi.org/10.1016/j.jaut.2007.07.004
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Genetically determined imbalance between serum levels of tumour necrosis factor (TNF) and interleukin (IL)-10 is associated with anti-Jo-1 and anti-Ro52 autoantibodies in patients with poly- and dermatomyositisJournal of Autoimmunity, 2006
- Mechanisms of Disease: pathogenesis of Crohn's disease and ulcerative colitisNature Clinical Practice Gastroenterology & Hepatology, 2006
- Detection of cytotoxic CD13-specific autoantibodies in sera from patients with ulcerative colitis and Crohn's diseaseJournal of Autoimmunity, 2006
- The role of cytokine mRNA stability in the pathogenesis of autoimmune diseaseAutoimmunity Reviews, 2006
- TNF pathophysiology in murine models of chronic inflammation and autoimmunitySeminars in Arthritis and Rheumatism, 2005
- Optimizing anti-TNF treatment in inflammatory bowel diseaseGastroenterology, 2004
- Tumour necrosis factor and other proinflammatory cytokines in systemic lupus erythematosus: a rationale for therapeutic interventionLupus, 2004
- Etanercept as Monotherapy in Patients with PsoriasisNew England Journal of Medicine, 2003
- The immunological and genetic basis of inflammatory bowel diseaseNature Reviews Immunology, 2003
- Inhibition of Thl responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cellsPublished by Elsevier ,1994